[HTML][HTML] Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies

E Carnero Contentti, J Correale - Journal of Neuroinflammation, 2021 - Springer
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central
nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis …

[HTML][HTML] Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide

JY Hor, N Asgari, I Nakashima, SA Broadley… - Frontiers in …, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …

[HTML][HTML] MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

J Sastre-Garriga, D Pareto, M Battaglini… - Nature Reviews …, 2020 - nature.com
Early evaluation of treatment response and prediction of disease evolution are key issues in
the management of people with multiple sclerosis (MS). In the past 20 years, MRI has …

[HTML][HTML] Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms

R Eid, NTT Arab, MT Greenwood - … et Biophysica Acta (BBA)-Molecular Cell …, 2017 - Elsevier
Iron is an essential micronutrient that is problematic for biological systems since it is toxic as
it generates free radicals by interconverting between ferrous (Fe 2+) and ferric (Fe 3+) forms …

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

M Watanabe, Y Nakamura, Z Michalak, N Isobe… - Neurology, 2019 - AAN Enterprises
Objective To test the hypothesis that serum levels of glial fibrillary acidic protein (GFAP) and
neurofilament light chain (NfL), which are an intermediate astrocyte and neuron filaments …

[HTML][HTML] The air we breathe: air pollution as a prevalent proinflammatory stimulus contributing to neurodegeneration

M Jankowska-Kieltyka, A Roman… - Frontiers in Cellular …, 2021 - frontiersin.org
Air pollution is regarded as an important risk factor for many diseases that affect a large
proportion of the human population. To date, accumulating reports have noted that …

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

BAC Cree, G Cutter, JS Wolinsky… - The Lancet …, 2020 - thelancet.com
Background There is an unmet need to develop therapeutic interventions directed at the
neurodegeneration that underlies progression in multiple sclerosis. High-dose …

Targeting B cells to modify MS, NMOSD, and MOGAD: part 1

J Graf, J Mares, M Barnett, O Aktas… - Neurology …, 2020 - AAN Enterprises
Ocrelizumab, rituximab, ofatumumab, ublituximab, inebilizumab, and evobrutinib are
immunotherapies that target various B cell–related proteins. Most of these treatments have …

Positron emission tomography in multiple sclerosis—straight to the target

B Bodini, M Tonietto, L Airas, B Stankoff - Nature reviews Neurology, 2021 - nature.com
Following the impressive progress in the treatment of relapsing–remitting multiple sclerosis
(MS), the major challenge ahead is the development of treatments to prevent or delay the …

Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders

Y Takai, T Misu, H Suzuki, T Takahashi, H Okada… - Brain, 2021 - academic.oup.com
Abstract Aquaporin 4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorder (AQP4-
IgG+ NMOSD) is an autoimmune astrocytopathic disease pathologically characterized by …